| Bevacizumab demonstrates prolonged disease stabilization in patients with ... - UroToday |
|
|
UroTodayThere are now a variety of therapies approved for the treatment of metastatic renal cell carcinoma (RCC). These include the immunotherapeutics, ... read more |